Statistics on Biotechnology Use  
Results by sector of operation
Company sector. Biotechnology results by main variables and no. of employees. 
Unidades: specified in variables

,Fewer than 250 employees,250 or more employees,Total,
No. of companies carrying out R&D in Biotechnology,975,81,1.056,
%Companies according to biotechnology used: Genetic code,35,46,36,
%Companies according to biotechnology used: Functional units,44,50,45,
%Companies according to biotechnology used: Cellular and tissue culturing and engineering,26,45,27,
%Companies according to biotechnology used: Bioprocesses,45,66,47,
%Companies according to biotechnology used: Sub-cellular organisms,8,15,8,
%Companies according to biotechnology used: Bio-computing,24,32,25,
%Companies according to biotechnology used: Nanobiotechnology,13,16,13,
%Companies according to biotechnology used: Other,15,13,15,
Companies in which biotechnology activities are: Main and/or exclusive,538,12,551,
Companies in which biotechnology activities are: A secondary line of business,164,19,183,
Companies in which biotechnology activities are: A tool necessary for production,273,50,323,
%Company by field(s) of ultimate application of biotechnology use: Human Health,49,52,49,
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture,22,3,20,
%Company by field(s) of ultimate application of biotechnology use: Food products,30,36,30,
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production,23,13,23,
%Company by field(s) of ultimate application of biotechnology use: Environment,13,17,13,
%Company by field(s) of ultimate application of biotechnology use: Industry,13,7,12,
Personnel in R&D in biotechnology (no. of persons),7.908,2.811,10.719,
Personnel in R&D in biotechnology (no. of persons): Researchers,4.660,1.470,6.131,
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants,3.247,1.341,4.588,
Personnel in R&D in biotechnology (no. of persons): women,4.291,1.749,6.040,
Personnel in R&D in biotechnology (no. of persons): (women) Researchers,2.520,891,3.411,
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants,1.772,857,2.629,
Personnel in R&D in biotechnology (FTE),5.651,3,2.099,5,7.750,8,
Personnel in R&D in biotechnology (FTE): Researchers,3.461,8,1.056,3,4.518,1,
Personnel in R&D in biotechnology (FTE): Technicians and assistants,2.189,4,1.043,3,3.232,7,
Personnel in R&D in biotechnology (FTE): women,3.133,9,1.337,5,4.471,4,
Personnel in R&D in biotechnology (FTE): (women) Researchers,1.912,650,7,2.562,7,
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants,1.221,9,686,8,1.908,7,
Internal expenditure on R&D (thousands of euros),511.004,168.555,679.558,
1) By nature of the expense: Current expenses,470.651,163.981,634.631,
1.1) Remuneration to researchers,167.208,61.649,228.857,
1.2) Remuneration to technicians and assistants,63.658,40.840,104.498,
1.3) Other current expenses,239.785,61.492,301.276,
2) By nature of the expense: Capital expenses,40.353,4.574,44.927,
2.1) Land and buildings,2.519,66,2.585,
2.2) Equipment and instruments,19.828,3.741,23.569,
2.3) Acquisition of specific R&D software,780,612,1.392,
2.4) Otros productos de propiedad intelectual específicos para I+D,17.226,155,17.381,
1) By origin of the funds: National funds,417.983,138.313,556.297,
1.1) Own funds,301.946,85.064,387.010,
1.2) From companies,49.801,36.223,86.025,
1.3) Public Administration funds,61.218,13.546,74.764,
1.4) From Universities,408,0,408,
1.5) From non profit private institutions,4.610,3.480,8.090,
1) By origin of the funds: Foreign funds,93.020,30.241,123.262,
2.1) From EU programmes,18.993,6.132,25.125,
2.2) Other foreign funds,74.027,24.109,98.137,
Purchase of R&D services in biotechnology (thousands of euros),86.267,61.292,147.558,
Purchase of R&D services in biotechnology (thousands of euros): In Spain,26.503,50.373,76.875,
Purchase of R&D services in biotechnology (thousands of euros): Abroad,59.764,10.919,70.683,
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital,50,25,49,
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information,14,11,14,
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources,16,15,16,
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain,13,15,13,
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets,18,13,18,
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of distribution and sales channels,19,8,18,
%Companies that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception,17,14,17,
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements,38,30,37,
%Companies that consider the following obstacles as very important considering biotechnology development: Time / cost,52,40,51,
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting,18,14,18,
% Companies that have requested biotechnology patents in Biotechnology,15,16,16,
Number of patents requested,602,144,746,
% Companies with income of an international origin related to biotechnological activities,23,9,16,23,3,
% Turnover representing income of an international origin related to biotechnological activities,5,7,0,7,1,2,
% Income of an international origin related to biotechnological activities distributed in: Income received from the EU,49,3,69,7,60,4,
% Income of an international origin related to biotechnological activities distributed in: Income received from other countries,50,7,30,3,39,6,
% Income of an international origin related to biotechnological activities by classification: Internacional trade in products and services,92,6,71,2,80,9,
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain,5,5,27,9,17,8,
% Income of an international origin related with activities according to the classification: Operating source abroad,1,9,0,8,1,3,
% Income of an international origin related with activities according to the classification: Other,0,1,.,0,1,
Notas:

.
'.'=numeric piece of data equal to zero not resulting from rounding 

 FTE: Full Time Equivalent
Fuente: National Statistics Institute